D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Chefs' Warehouse
CHEF
$3.9B
| $2.95M | ﹤0.01% |
+292,881
| New | +$8.68M |
|
1802
New Oriental
EDU
$7.94B
| $2.95M | ﹤0.01% |
27,225
+21,789
| +401% | +$2.8M |
|
1803
CALL
Expedia Group
EXPE
$33.4B
| $2.94M | ﹤0.01% |
52,300
+21,600
| +70% | +$2.07M |
|
1804
Essex Property Trust
ESS
$18.7B
| $2.94M | ﹤0.01% |
13,362
-12,869
| -49% | -$3.7M |
|
1805
Interface
TILE
$1.96B
| $2.94M | ﹤0.01% |
389,074
-111,989
| -22% | -$1.56M |
|
1806
Valmont Industries
VMI
$9.61B
| $2.94M | ﹤0.01% |
27,753
-11,957
| -30% | -$1.55M |
|
1807
V2X
VVX
$2.73B
| $2.94M | ﹤0.01% |
71,004
-56,694
| -44% | -$2.89M |
|
1808
CALL
Expeditors International
EXPD
$22.4B
| $2.94M | ﹤0.01% |
+44,000
| New | +$3.14M |
|
1809
CALL
Teleflex
TFX
$5.8B
| $2.93M | ﹤0.01% |
10,000
| – | – |
|
|
GPMT
1810
Granite Point Mortgage Trust
GPMT
$62.8M
| $2.92M | ﹤0.01% |
576,749
+547,477
| +1,870% | +$8.29M |
|
1811
BILL Holdings
BILL
$4.47B
| $2.92M | ﹤0.01% |
+85,300
| New | +$4.04M |
|
1812
PUT
Acuity Brands
AYI
$10.1B
| $2.9M | ﹤0.01% |
33,900
| – | – |
|
1813
Renasant Corp
RNST
$4B
| $2.89M | ﹤0.01% |
132,510
+55,426
| +72% | +$1.65M |
|
1814
CALL
MarketAxess Holdings
MKTX
$4.19B
| $2.89M | ﹤0.01% |
8,700
-36,700
| -81% | -$12.8M |
|
1815
Rocket Pharmaceuticals
RCKT
$355M
| $2.89M | ﹤0.01% |
207,403
+188,976
| +1,026% | +$3.74M |
|
1816
PUT
MSCI
MSCI
$41.5B
| $2.89M | ﹤0.01% |
+10,000
| New | +$2.83M |
|
1817
Carlyle Secured Lending
CGBD
$710M
| $2.88M | ﹤0.01% |
552,692
-7,522
| -1% | -$89.1K |
|
1818
CALL
Ulta Beauty
ULTA
$20.7B
| $2.88M | ﹤0.01% |
16,400
-47,500
| -74% | -$11.8M |
|
|
FL
1819
DELISTED
Foot Locker
FL
| $2.88M | ﹤0.01% |
130,558
-110,587
| -46% | -$3.76M |
|
|
STMP
1820
CALL
DELISTED
Stamps.com, Inc.
STMP
| $2.88M | ﹤0.01% |
22,100
-48,800
| -69% | -$5.12M |
|
1821
Arlo Technologies
ARLO
$1.51B
| $2.87M | ﹤0.01% |
1,182,292
+358,111
| +43% | +$1.24M |
|
1822
PUT
AstraZeneca
AZN
$263B
| $2.87M | ﹤0.01% |
32,100
| – | – |
|
|
ITCI
1823
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.87M | ﹤0.01% |
186,447
-44,966
| -19% | -$977K |
|
1824
Blue Owl Capital
OBDC
$5.42B
| $2.86M | ﹤0.01% |
248,055
+206,676
| +499% | +$3.03M |
|
1825
Plexus
PLXS
$6.78B
| $2.85M | ﹤0.01% |
52,285
-4,680
| -8% | -$316K |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.